查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511837

美国糖尿病足溃疡治疗市场规模、份额、趋势分析报告：按治疗、溃疡类型、最终用途和细分市场预测，2024-2030 年

U.S. Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapy Device, Wound Care Dressing), By Ulcer Type (Ulcer, Neuro-ischemic Ulcer), By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

美国糖尿病足溃疡治疗市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，预计 2030 年美国糖尿病足溃疡治疗市场规模将达到 24.7 亿美元，2024 年至 2030 年复合年增长率为 5.25%。

推动市场开拓的主要因素包括全国糖尿病发病率的上升、人口老化、治疗技术的进步、研发力度的加强以及生活方式的改变。例如，人口研究所预测，65岁及以上的美国人数量预计将从2022年的5,800万增加到2050年的8,200万，成长47%。

由于糖尿病足溃疡是一种常见的併发症，美国的糖尿病流行对扩大市场发挥了重要作用。例如，根据国际糖尿病联盟的数据，2021年美国约有3,221万人在20岁至79岁之间的糖尿病患者，预计2045年将进一步增加至3,628万人。此外，医疗技术和治疗方法的进步也促进了市场的成长。先进的创伤护理产品、生物工程组织和再生医学技术等创新为糖尿病足溃疡管理提供了更有效和高效的解决方案。

此外，医疗保健提供者和患者对糖尿病足溃疡早期发现和适当治疗重要性的认识不断提高，正在推动市场成长。医疗保健专业人员和患者都知道，早期发现糖尿病足溃疡需要仔细的足部护理和定期检查。这种认识的提高促使人们采取积极的方法来管理糖尿病併发症，从而改善患者的治疗效果并减少严重溃疡。此外，持续的研究和开发工作对于推进糖尿病足溃疡的治疗选择和技术至关重要。这些持续的努力带来了创新的解决方案，包括新的治疗方法、诊断工具和预防方法，扩大了医疗保健提供者的选择范围。

主要市场参与企业的存在以及每家公司为保持市场竞争力而采取的各种倡议，例如产品核可、产品发布、联盟、併购和业务扩张，预计将有助于整体市场的成长。例如，2024 年 4 月，Molnlycke Health Care 宣布计划收购 PGF Industry Solutions GmbH，这是一家以生产伤口清洗和保湿产品 Granudacyn 而闻名的奥地利公司。

美国糖尿病足溃疡治疗市场报告亮点

  • 以治疗来看，生物製药领域将在2023年占据市场主导地位，销售份额将超过30%。
  • 预计治疗设备领域在预测期内将以最快的复合年增长率成长。
  • 按溃疡类型划分，神经缺血性溃疡在 2023 年占据最大市场占有率。
  • 预计 2024 年至 2030 年，缺血性溃疡部分将以最快的速度成长。
  • 从最终用途来看，医院和诊所将在 2023 年引领市场。
  • 2023 年，北美占据市场主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国糖尿病足溃疡治疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国糖尿病足溃疡治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国糖尿病足溃疡治疗市场：治疗评估与趋势分析

  • 细分仪表板
  • 美国糖尿病足溃疡治疗市场：治疗变异分析
  • 2018-2030年美国糖尿病足溃疡治疗市场规模及趋势分析（依治疗）
  • 创伤护理敷料
  • 生物製药
  • 治疗设备
  • 抗生素
  • 其他的

第五章美国糖尿病足溃疡治疗市场：溃疡类型估计与趋势分析

  • 细分仪表板
  • 美国糖尿病足溃疡治疗市场：溃疡类型变异分析
  • 2018-2030年美国糖尿病足溃疡治疗市场规模及趋势分析（依溃疡类型）
  • 2018-2030年市场规模及预测及趋势分析
  • 神经病变溃疡
  • 缺血性溃疡
  • 神经缺血性溃疡

第六章美国糖尿病足溃疡治疗市场：最终用途估计与趋势分析

  • 细分仪表板
  • 美国糖尿病足溃疡治疗市场：最终用途变化分析
  • 2018-2030 年美国糖尿病足溃疡治疗市场规模与趋势分析（依最终用途）
  • 医院
  • 门诊手术中心
  • 居家照护

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2023年主要企业市场占有率分析
  • 公司定位分析
  • 公司分类（新兴企业、创新企业、领导者）
  • 公司简介
    • ConvaTec, Group Plc
    • 3M Health Care
    • Coloplast Corp.
    • Smith &Nephew Plc
    • B Braun Melsungen AG
    • Medline Industries, LP.
    • Molnlycke Health Care AB
    • Medtronic Plc
Product Code: GVR-4-68040-302-9

U.S. Diabetic Foot Ulcer Treatment Market Growth & Trends:

The U.S. diabetic foot ulcer treatment market size is anticipated to reach USD 2.47 billion by 2030, expanding at a CAGR of 5.25% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include the increasing occurrence of diabetes nationwide, an aging population, advancements in treatment technology, rising research and development efforts, and shifts in lifestyle patterns. For instance, according to the Population Reference Bureau's projections, the population of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by the year 2050, reflecting a 47% increase.

The prevalence of diabetes in the U.S. plays a significant role in market expansion, as diabetic foot ulcers are a common complication of the disease. For instance, according to the International Diabetes Federation, in 2021 there were about 32.21 million diabetes patients aged 20-79 years in the U.S. which are further expected to increase to 36.28 million by 2045. Furthermore, the advancements in medical technology and treatment modalities contribute to the growth of the market. Innovations such as advanced wound care products, bioengineered tissues, and regenerative medicine techniques offer more effective and efficient solutions for diabetic foot ulcer management.

Furthermore, the increasing awareness among healthcare providers and patients of the importance of early detection and proper treatment of diabetic foot ulcers is driving the market growth. Both healthcare professionals and patients understand the necessity of careful foot care and regular screenings to catch diabetic foot ulcers early. This heightened awareness encourages a proactive approach to managing complications of diabetes, leading to better outcomes for patients and fewer severe ulcers. Additionally, ongoing research and development efforts are essential in advancing treatment options and technologies for managing diabetic foot ulcers. These continued efforts result in innovative solutions, such as new therapies, diagnostic tools, and preventive measures, which expand the options available to healthcare providers.

Presence of major market participants and various initiatives undertaken by them to stay competitive in the market such as product approval, product launch, partnership, merger and acquisition, expansion, etc. are expected to contribute to the overall market growth. For instance, in April 2024, Molnlycke Health Care has announced its plans to acquire P.G.F. Industry Solutions GmbH, an Austrian company known for producing Granudacyn, a line of wound cleansing and moisturizing products.

U.S. Diabetic Foot Ulcer Treatment Market Report Highlights:

  • Based on treatment, the biologics segment dominated the market by capturing a revenue share of more than 30% in 2023
  • The therapy devices segment is anticipated to grow at the fastest CAGR during the forecast period
  • Based on ulcer type, the neuro-ischemic ulcers segment held the largest market share in 2023
  • The Ischemic ulcers segment is expected to grow at a fastest rate from 2024 to 2030
  • Based on end-use, hospitals and clinics led the market in 2023
  • North America dominated the market in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Ulcer Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment outlook
    • 2.2.2. Ulcer type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of diabetes
      • 3.2.1.2. Aging population
      • 3.2.1.3. Advancements in treatment technology
      • 3.2.1.4. Lifestyle changes
      • 3.2.1.5. Growing R&D activities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
  • 3.3. U.S. Diabetic Foot Ulcer Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global U.S. Diabetic Foot Ulcer Treatment Market Movement Analysis
  • 4.3. Global U.S. Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Wound Care Dressings
    • 4.4.1. Wound care dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Alginate dressings
      • 4.4.1.1.1. Alginate dressing market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Hydrofiber dressings
      • 4.4.1.2.1. Hydrofiber dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Foam dressings
      • 4.4.1.3.1. Foam dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. Film dressing
      • 4.4.1.4.1. Film dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Hydrocolloid dressings
      • 4.4.1.5.1. Hydrocolloid dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.6. Surgical Dressings
      • 4.4.1.6.1. Surgical dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.7. Hydrogel dressings
      • 4.4.1.7.1. Hydrogel dressings market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Biologics
    • 4.5.1. Biologics market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.5.1.1. Growth factors
      • 4.5.1.1.1. Growth factors market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.5.1.2. Skin grafts
      • 4.5.1.2.1. Skin grafts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Therapy devices
    • 4.6.1. Therapy devices market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.6.1.1. Negative pressure wound therapy
      • 4.6.1.1.1. Negative pressure wound therapy market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.6.1.2. Ultrasound therapy
      • 4.6.1.2.1. Ultrasound therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Antibiotic medicine
    • 4.7.1. Antibiotic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global U.S. Diabetic Foot Ulcer Treatment Ulcer Type Market Movement Analysis
  • 5.3. Global U.S. Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Ulcer Type, 2018 to 2030 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5. Neuropathic Ulcers
    • 5.5.1. Neuropathic ulcers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Ischemic Ulcers
    • 5.6.1. Ischemic ulcers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Neuro-ischemic Ulcers
    • 5.7.1. Neuro-ischemic ulcers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Diabetic Foot Ulcer Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global U.S. Diabetic Foot Ulcer Treatment End Use Market Movement Analysis
  • 6.3. Global U.S. Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Surgery Center
    • 6.5.1. Ambulatory surgery center market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Homecare
    • 6.6.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2023
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. ConvaTec, Group Plc
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. 3M Health Care
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Coloplast Corp.
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Smith & Nephew Plc
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. B Braun Melsungen AG
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Medline Industries, LP.
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. Molnlycke Health Care AB
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Medtronic Plc
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. U.S. diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
  • Table 4 U.S. U.S. diabetic foot ulcer treatment market by ulcer type, 2018 - 2030 (USD Million)
  • Table 5 U.S. U.S. diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
  • Table 6 Participant's overview
  • Table 7 Financial performance
  • Table 8 Key companies undergoing expansions
  • Table 9 Key companies undergoing acquisitions
  • Table 10 Key companies undergoing collaborations
  • Table 11 Key companies launching new products/services
  • Table 12 Key companies undergoing partnerships
  • Table 13 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2023 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Porter's analysis
  • Fig. 13 SWOT analysis
  • Fig. 14 US diabetic foot ulcer treatment market: Treatment outlook and key takeaways
  • Fig. 15 US diabetic foot ulcer treatment market: Treatment movement analysis
  • Fig. 16 Wound care dressings market, 2018 - 2030 (USD Million)
  • Fig. 17 Alginate dressings market, 2018 - 2030 (USD Million)
  • Fig. 18 Hydrofiber dressings market, 2018 - 2030 (USD Million)
  • Fig. 19 Foam dressings market, 2018 - 2030 (USD Million)
  • Fig. 20 Film dressing market, 2018 - 2030 (USD Million)
  • Fig. 21 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
  • Fig. 22 Surgical dressings market, 2018 - 2030 (USD Million)
  • Fig. 23 Hydrogel dressings market, 2018 - 2030 (USD Million)
  • Fig. 24 Biologics market, 2018 - 2030 (USD Million)
  • Fig. 25 Growth factors market, 2018 - 2030 (USD Million)
  • Fig. 26 Skin grafts market, 2018 - 2030 (USD Million)
  • Fig. 27 Therapy devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Negative pressure Wound Therapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Ultrasound therapy market, 2018 - 2030 (USD Million)
  • Fig. 30 Antibiotic medications market, 2018 - 2030 (USD Million)
  • Fig. 31 Others market, 2018 - 2030 (USD Million)
  • Fig. 32 US diabetic foot ulcer treatment market: Ulcer type outlook and key takeaways
  • Fig. 33 US diabetic foot ulcer treatment market: Ulcer type movement analysis
  • Fig. 34 Neuropathic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 35 Ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 36 Neuro-ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. diabetic foot ulcer treatment market: End Use outlook and key takeaways
  • Fig. 38 U.S. diabetic foot ulcer treatment market: End Use movement analysis
  • Fig. 39 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 40 Ambulatory surgery centre market, 2018 - 2030 (USD Million)
  • Fig. 41 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 42 Heat map analysis
  • Fig. 43 Market participant categorization
  • Fig. 44 U.S. diabetic foot ulcer treatment market share analysis, 2023
  • Fig. 45 Strategy framework